Rye bread is a versatile ingredient when it comes to making delectable sandwiches, from a classic ham and cheese to ...

In 2025, Cellectis will continue to focus its efforts and expenses on advancing its core clinical trials BALLI-01 and NATHALI-01, while building the next generation of genomic medicines to address ...